A detailed history of North Crest Asset Manangement, LLC transactions in Biolife Solutions Inc stock. As of the latest transaction made, North Crest Asset Manangement, LLC holds 14,700 shares of BLFS stock, worth $391,167. This represents 0.01% of its overall portfolio holdings.

Number of Shares
14,700
Previous 14,700 -0.0%
Holding current value
$391,167
Previous $367,000 3.81%
% of portfolio
0.01%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 15, 2024

SELL
$15.35 - $18.82 $7,675 - $9,410
-500 Reduced 3.29%
14,700 $272,000
Q1 2023

Apr 25, 2023

BUY
$17.67 - $26.07 $14,136 - $20,856
800 Added 5.56%
15,200 $330,000
Q4 2022

Feb 01, 2023

BUY
$16.95 - $25.07 $25,425 - $37,605
1,500 Added 11.63%
14,400 $262,000
Q1 2022

Apr 18, 2022

BUY
$20.81 - $37.29 $268,449 - $481,041
12,900 New
12,900 $293,000

Others Institutions Holding BLFS

About BIOLIFE SOLUTIONS INC


  • Ticker BLFS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 42,684,400
  • Market Cap $1.14B
  • Description
  • BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...
More about BLFS
Track This Portfolio

Track North Crest Asset Manangement, LLC Portfolio

Follow North Crest Asset Manangement, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of North Crest Asset Manangement, LLC, based on Form 13F filings with the SEC.

News

Stay updated on North Crest Asset Manangement, LLC with notifications on news.